In his debut blog, Franco De Crescenzo summarises a narrative review that finds good evidence for the short-term pharmacological treatment of ADHD.
[read the full story...]
In his debut blog, Franco De Crescenzo summarises a narrative review that finds good evidence for the short-term pharmacological treatment of ADHD.
[read the full story...]
In her debut blog, Anjana Greedharee reviews a co-produced, participatory qualitative study on the experiences of living with mental health problems 
during the COVID-19 pandemic in the UK.
[read the full story...]
Mark Horowitz and Joanna Moncrieff consider a new #ActiveIngredientsMH review published today in The Lancet Psychiatry, which looks at the knowns and unknowns of antidepressant treatment in young people with depression and anxiety: efficacy, predictors, and mechanisms of action.
[read the full story...]
Sadhbh Byrne reviews a recent mixed-methods study on client acceptability of a psychosocial and psychoeducational group intervention for repeat suicide attempts. The ‘Psychosocial/psychoeducation Intervention for recurrent Suicide Attempts’ (PISA), or ‘Skills for Safer Living’ (SfSL).
[read the full story...]
Anya Borissova summarises a recent randomised placebo-controlled trial that evaluated ketamine metabolites, clinical response, and gamma power for major depression.
[read the full story...]
A group of UCL MSc students review a recent mixed-methods study which suggests that online disclosure of negative emotions and experiences (posted to Facebook) are linked with depression symptoms in US college students.
[read the full story...]
Mark Horowitz considers a recent article written by Adele Framer, Founder of SurvivingAntidepressants.org, which describes how best to help people who are tapering off antidepressants.
[read the full story...]
In her debut blog, Margherita Zenoni explores a mixed methods survey, which finds that social media support groups may be harmful for some people with OCD or related disorders.
[read the full story...]
Imogen Bell blogs about a recent randomised controlled trial of the SlowMo app, which aimed to slow down thinking patterns and correct interpretation biases in people experiencing paranoia.
[read the full story...]
Joseph Pierre appraises a recent meta-analysis on long-acting injectable antipsychotics compared to oral antipsychotic medication for the maintenance treatment of schizophrenia.
[read the full story...]